This is the authors' abstract. We don't add key points for this paper.
The integration of single-port surgery, new robotic platforms, 3D models and artificial intelligence in urological oncology promises transformative impacts on diagnosis, treatment and cost-effectiveness. Despite benefits like enhanced precision and expanded surgical access, challenges such as high costs, training needs, and technological integration barriers persist. Collaboration and further research are critical to optimize outcomes, improve safety protocols, and ensure equitable global access to these innovations.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bignante et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: